Finance house Yorkville has elected to convert a further portion of tranche 1 of the convertible loan facility it provides to ValiRx Plc (LON:VAL).
Yorkville converted US$150,000 of tranche 1 convertible loan notes, plus accrued interest of US$15,840, into 2.39mln shares at a conversion price of 5.625p per share.
Shares of the cancer treatments developer currently trade at around 5.15p, having fallen from 5.37p on news of the conversion.